Cargando…

An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score

INTRODUCTION: We conducted an external validation study to examine the correlation of a previously published claims-based index for rheumatoid arthritis severity (CIRAS) with disease activity score in 28 joints calculated by using C-reactive protein (DAS28-CRP) and the multi-dimensional health asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Rishi J, Solomon, Daniel H, Weinblatt, Michael E, Shadick, Nancy, Kim, Seoyoung C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394559/ https://www.ncbi.nlm.nih.gov/pubmed/25880932 http://dx.doi.org/10.1186/s13075-015-0599-0

Ejemplares similares

The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28
por: Sato, Masayo, et al.
Publicado: (2006)

Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach
por: Feldman, Candace H., et al.
Publicado: (2019)

Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
por: Felson, David, et al.
Publicado: (2022)

Validity of the Nurses’ health study physical activity questionnaire in estimating physical activity in adults with rheumatoid arthritis
por: Quinn, Thomas, et al.
Publicado: (2017)

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study
por: Alemao, Evo, et al.
Publicado: (2020)

Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement
por: Solomon, Daniel H., et al.
Publicado: (2017)

Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry
por: Shadick, Nancy, et al.
Publicado: (2023)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia
por: Lee, Yvonne C., et al.
Publicado: (2016)

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity
por: Zhuo, Joe, et al.
Publicado: (2022)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: Shadick, Nancy A., et al.
Publicado: (2019)

Validation of rheumatoid arthritis diagnoses in health care utilization data
por: Kim, Seo Young, et al.
Publicado: (2011)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
por: Das, Priyam, et al.
Publicado: (2023)

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
por: Curtis, Jeffrey R, et al.
Publicado: (2012)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis
por: Chang, Hui-Hsin, et al.
Publicado: (2012)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort
por: Ahmad, Harris A., et al.
Publicado: (2018)

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis
por: Jin, Yinzhu, et al.
Publicado: (2023)

Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis
por: Curtis, Jeffrey R, et al.
Publicado: (2019)

The validity of the claims-based definition of rheumatoid arthritis evaluated in 64 hospitals in Japan
por: Kubota, Kiyoshi, et al.
Publicado: (2021)

Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients With Rheumatoid Arthritis
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments
por: Kim, Seo Young, et al.
Publicado: (2011)

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
por: Ljung, Lotta, et al.
Publicado: (2018)

Automatic Prediction of Rheumatoid Arthritis Disease Activity from the Electronic Medical Records
por: Lin, Chen, et al.
Publicado: (2013)

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
por: Jin, Yinzhu, et al.
Publicado: (2017)

Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis
por: Ercan, Altan, et al.
Publicado: (2012)

Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study
por: Ting, Gladys, et al.
Publicado: (2008)

External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure
por: Mahesri, Mufaddal, et al.
Publicado: (2021)

Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis
por: Ellrodt, Jack, et al.
Publicado: (2022)

Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drugs
por: Pawar, Ajinkya, et al.
Publicado: (2021)

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis
por: Curtis, Jeffrey R, et al.
Publicado: (2011)

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity
por: Sauer, Brian C., et al.
Publicado: (2017)

Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Drugs: A Cohort Study
por: Desai, Rishi J., et al.
Publicado: (2020)

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
por: Centola, Michael, et al.
Publicado: (2013)

Methotrexate: who would have predicted its importance in rheumatoid arthritis?
por: Weinblatt, Michael E.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dpi3j8f0rfu6mnqlc5sa74rmu2